Sign Up to like & get
recommendations!
1
Published in 2022 at "Biomolecules"
DOI: 10.3390/biom13010088
Abstract: Efavirenz (Sustiva®) is a first-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat human immunodeficiency virus (HIV) type 1 infection or to prevent the spread of HIV. In 1998, the FDA authorized efavirenz for the…
read more here.
Keywords:
efavirenz;
hiv;
efavirenz history;
development future ... See more keywords